Alex Goldberg

Bristol-Myers Squibb Company (NYSE:BMY) and Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) Added to Equity Profile Report's NYSE Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/08/2014 -- Equity Profile Report expands its NYSE Decliners Weekly Watch List adding Bristol-Myers Squibb Company (NYSE:BMY) and Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX).

Bristol-Myers Squibb Company (NYSE:BMY) a biopharmaceutical company that discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide closed down in its previous session (-0.15%) on 8,966,522 shares traded after Bristol-Myers Squibb Announced to Report Results for Fourth Quarter, Full Year 2013 on January 24, 2014. Bristol-Myers Squibb Company (NYSE:BMY) is currently down (-3.65%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Bristol-Myers Squibb Company (NYSE:BMY)

Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) a company that engages in the exploration of mineral resource properties closed down in its previous session (-0.97%) on 8,746,291 shares traded. Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) is currently down (-4.02%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com